1. Home
  2. OPEN vs APGE Comparison

OPEN vs APGE Comparison

Compare OPEN & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opendoor Technologies Inc

OPEN

Opendoor Technologies Inc

HOLD

Current Price

$5.27

Market Cap

4.7B

Sector

Finance

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$92.39

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPEN
APGE
Founded
2014
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.7B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
OPEN
APGE
Price
$5.27
$92.39
Analyst Decision
Sell
Strong Buy
Analyst Count
3
13
Target Price
$1.67
$109.67
AVG Volume (30 Days)
26.4M
1.0M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,371,000,000.00
N/A
Revenue This Year
$3.04
N/A
Revenue Next Year
$53.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$32.36
52 Week High
$10.87
$90.69

Technical Indicators

Market Signals
Indicator
OPEN
APGE
Relative Strength Index (RSI) 58.88 73.46
Support Level $5.24 $73.06
Resistance Level $5.69 N/A
Average True Range (ATR) 0.30 3.31
MACD 0.08 0.71
Stochastic Oscillator 81.79 85.31

Price Performance

Historical Comparison
OPEN
APGE

About OPEN Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: